CMHC Masterclass On Demand: Who Best to Stem the Cardiometabolic Tsunami

While a substantial body of research demonstrates the need to address the global epidemic of metabolic syndrome, and the constellation of associated cardiometabolic risk factors simultaneously, the majority of them are still treated as separate entities.

The engaging and interactive session recordings from this Masterclass cover experts across specialties on the current state of affairs and advances in cardiometabolic disease including team based-care, telemedicine, cardio-renal risk reduction, obesity management, and much more.

Target Audience

The Cardiometabolic Health Congress (CMHC) is designed for advanced level clinicians responsible for the prevention, diagnosis, and management of cardiometabolic risk including cardiologists, endocrinologists, diabetologists, lipidologists, pharmacists, primary care clinicians (PCPs), nurse practitioners (NPs), physician assistants (PAs), and other allied health professionals.

Learning Objectives

After completing this activity, the participant should be better able to:

  • Discuss the interrelationships among cardiometabolic risk factors and their impact on the development of cardiometabolic diseases, including diabetes, dyslipidemia, hypertension, obesity, kidney disease, and cardiovascular disease
  • Interpret the latest evidence and guidelines about the role of SGLT-2is and GLP-1 RAs in addressing cardiometabolic risk in patients with and without T2DM.
  • Describe the efficacy and safety of foundational and newer therapies for heart failure and dyslipidemia.
  • Outline strategies aimed at timely screening and prevention of cardiometabolic disease, including hypertension, blood glucose, and lipid control, as well as overweight and obesity management.
  • Develop individualized treatment regimens for patients with cardiometabolic disease based on the efficacy and safety of current and new pharmacotherapies, patient comorbidities and preferences, and multi-disciplinary care strategies in order to optimize outcomes.
  • Review the impact of technology and remote monitoring devices, including home blood pressure and continuous glucose monitors in ensuring the continuum of care for cardiometabolic patients in the COVID-19 era.
  • List specific updates in telemedicine services, billing, and legal implications as a result of the COVID-19 pandemic.
  • Incorporate technology and remote monitoring when appropriate to ensure the continuum of care for patients with cardiometabolic diseases in the COVID-19 era.
Course summary
Available credit: 
  • 6.75 ACPE Pharmacy
  • 6.75 AMA PRA Category 1 Credit™
  • 6.75 ANCC
  • 6.75 CDE
  • 6.75 Participation
Course opens: 
Course expires: 

Keith C. Ferdinand, MD, FACC, FAHA (Chair)
Professor of Medicine
Tulane University School of Medicine
Tulane Heart and Vascular Institute
New Orleans, LA

Anne L. Peters, MD
Professor, Keck School of Medicine
Director, Clinical Diabetes Programs
University of Southern California
Los Angeles, CA

Harold E. Bays, MD
Medical Director/President
Louisville Metabolic and Atherosclerosis
Research Center, Inc.
Louisville, KY

Ileana L. Piña, MD, MPH, FAHA, FACC
Professor of Medicine, Wayne State University
Clinical Professor of Medicine
Central Michigan University
Mount Pleasant, MI

Robert H. Eckel, MD
Professor of Medicine, Emeritus
Division of Endocrinology, Metabolism and Diabetes
Division of Cardiology
Professor of Physiology and Biophysics, Emeritus
Charles A. Boettcher II Chair in Atherosclerosis
University of Colorado Anschutz Medical Campus
Aurora, CO

Donna H. Ryan, MD
Professor Emerita
Interim Executive Director
Pennington Biomedical Research Center
New Orleans, LA

Karol Harshaw-Ellis, MSN, DNP, GNP, ACNP, FHFSA
Director of Outreach
Same Day Access Heart Failure Clinic
Duke University-Department of Cardiology-Heart Failure
Durham, NC

Daichi Shimbo, MD
Professor of Medicine
Columbia University Irving Medical Center
New York, NY

Darren McGuire, MD, MHSc
Professor of Internal Medicine
University of Texas Southwestern Medical Center
Parkland Health and Hospital System
Dallas, TX

Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College Thomas Jefferson University
Philadelphia, PA

Erin D. Michos, MD, MHS
Associate Professor of Medicine (Cardiolology) and Epidemiology
Director of Women’s Cardiovascular Health
Associate Director of Preventive Cardiology
Johns Hopkins University School of Medicine
Baltimore, MD

Ahmed M. Soliman, MD
Preventive Cardiology, Cardiology
Houston Methodist DeBakey Cardiology Associates
Houston, TX

Margo Minissian, PhD, ACNP
Nurse Scientist
Cardiology Nurse Practitioner
Clinical Lipid Specialist
Barbra Streisand Women’s Heart Center, Cedars-Sinai Heart Institute
Los Angeles, CA

Katherine R. Tuttle, MD, FASN, FACP, FNKF
Executive Director for Research, Providence Health Care
Professor of Medicine, University of Washington
Co-Principal Investigator, Institute of Translational Health Sciences,
University of Washington/Providence Health & Services
Spokane, WA



6.75 hours

CMHC Masterclass Who Best to Stem the Cardiometabolic Tsunami - Cardiology, Endocrinology and Primary Care is supported in part by an independent and unrestricted educational grant from Merck Sharp & Dohme Corp.

image   image   image

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Tarsus Cardio Inc. dba Cardiometabolic Health Congress (CMHC). Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

The maximum number of hours awarded for this Continuing Nursing Education activity is 6.75 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate. 

Postgraduate Institute for Medicine designates this continuing education activity for 6.75 contact hour(s) (.675 CEUs) of the Accreditation Council for Pharmacy Education.

This is a knowledged-based activity. Universal Activity Numbers (UAN): #JA4008162-9999-21-2662-H01-P

For Pharmacists: Upon completing the post-test and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 – 6 weeks.

This program offers 6.75 CPEUs for dieticians.

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

A full listing of faculty disclosures PDF icon can be downloaded here.

Planners and Managers
The PIM planners and managers have nothing to disclose. The CMHC planners and managers have nothing to disclose.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

There are no registration fees for this activity. During the period March 31, 2021 through March 31, 2022, participants must read the learning objectives and faculty disclosures, study the educational activity, obtain a score of 75% or better on the post-test, and complete the evaluation. Upon completing, your certificate will be available for print. For questions about receiving certificates, please contact us at

For questions about the accreditation of this activity, please visit

For Pharmacists: Please complete the evaluation instructions above. Upon registering and completing the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service within 4-6 weeks.

Available Credit

  • 6.75 ACPE Pharmacy
  • 6.75 AMA PRA Category 1 Credit™
  • 6.75 ANCC
  • 6.75 CDE
  • 6.75 Participation
Please login or register to take this course.

There are no registration fees for this activity. Please enroll and proceed with the course instructions.

Required Hardware/software

A computer with an internet connection

Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser

Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.